Cannabigerol (CBG), a non-intoxicating cannabinoid, interacts with the endocannabinoid system (ECS)—a key regulator of endocrine and metabolic processes. By modulating CB1 and CB2 receptors, CBG influences energy balance, insulin sensitivity, and inflammation . This interaction supports ECS-mediated feedback loops that coordinate hormonal systems, impacting appetite, glucose metabolism, and overall homeostasis . Preclinical studies suggest CBG’s potential in enhancing metabolic health and reducing inflammation .Cannabigerol (CBG), a non-intoxicating cannabinoid, interacts with the endocannabinoid system (ECS)—a key regulator of endocrine and metabolic processes. By modulating CB1 and CB2 receptors, CBG influences energy balance, insulin sensitivity, and inflammation . This interaction supports ECS-mediated feedback loops that coordinate hormonal systems, impacting appetite, glucose metabolism, and overall homeostasis . Preclinical studies suggest CBG’s potential in enhancing metabolic health and reducing inflammation .
Reviews
There are no reviews yet.